{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:27:54Z","timestamp":1771662474871,"version":"3.50.1"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T00:00:00Z","timestamp":1493251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"UNITAID"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0176323","type":"journal-article","created":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T19:46:34Z","timestamp":1493322394000},"page":"e0176323","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["The performance of BD FACSPresto\u2122 for CD4 T-cell count, CD4% and hemoglobin concentration test in Ethiopia"],"prefix":"10.1371","volume":"12","author":[{"given":"Gebremedhin","family":"Gebremicael","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohanes","family":"Belay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fitsum","family":"Girma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yemane","family":"Abreha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsbeha","family":"Gebreegziabxier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simret","family":"Tesfaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zelalem","family":"Messele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibeltal","family":"Assefa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahrie","family":"Bellete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desta","family":"Kassa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Vojnov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,4,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"GIORGI J V. Characterization of T Lymphocyte Subset Alterations by Flow Cytometry in HIV Disease. Annals of the New York Academy of Sciences. 1993 Mar;677(1 Clinical Flow):126\u201337.","DOI":"10.1111\/j.1749-6632.1993.tb38771.x"},{"issue":"17","key":"ref2","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1097\/00002030-200111230-00006","article-title":"HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy","volume":"15","author":"TR Sterling","year":"2001","journal-title":"AIDS"},{"issue":"12","key":"ref3","doi-asserted-by":"publisher","first-page":"946","DOI":"10.7326\/0003-4819-126-12-199706150-00003","article-title":"Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection","volume":"126","author":"JW Mellors","year":"1997","journal-title":"Annals of internal medicine"},{"key":"ref4","unstructured":"Ministry of Health (MoH). Supplement to the 2014 National Comprehensive HIV Prevention, Care and Treatment Guideline of Ethiopia to Address HIV test and Start. 2016;"},{"key":"ref5","unstructured":"FMOH. Guidelines for the implementation of POC CD4 testing technologies in Ethiopia. 2013;(June)."},{"issue":"4","key":"ref6","doi-asserted-by":"publisher","first-page":"e1000056","DOI":"10.1371\/journal.pmed.1000056","article-title":"Rapid scale-up of antiretroviral treatment in Ethiopia: successes and system-wide effects","volume":"6","author":"Y Assefa","year":"2009","journal-title":"PLoS medicine"},{"key":"ref7","unstructured":"World Health Organization (WHO). Technical Brief on CD4 Technologies. 2011;(Feb):1\u201337."},{"key":"ref8","unstructured":"UNITAID. HIV \/ AIDS Diagnostics Technology Landscape 5 th edition. 2015;(October)."},{"key":"ref9","unstructured":"World Health Organization (WHO). WHO | WHO list of prequalified in vitro diagnostic products. World Health Organization; 2014;"},{"issue":"6","key":"ref10","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1097\/QAD.0b013e328344f424","article-title":"Accurate CD4 T-cell enumeration and antiretroviral drug toxicity monitoring in primary healthcare clinics using point-of-care testing","volume":"25","author":"V Jani I","year":"2011","journal-title":"AIDS (London, England)"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7448\/IAS.17.1.18809","article-title":"Impact of point-of-care CD4 testing on linkage to HIV care: A systematic review","volume":"17","author":"E Wynberg","year":"2014","journal-title":"Journal of the International AIDS Society"},{"key":"ref12","unstructured":"BD MultitestTM, CD3\/CD8\/CD45\/CD4. 2016;"},{"key":"ref13","unstructured":"(BD) BD. BD FACSCalibur Instructions For Use. User\u2019s guide. 2007;(32)."},{"key":"ref14","unstructured":"(BD) BD. BD FACSPresto TM near-patient CD4 counter instruction for use. 2016."},{"key":"ref15","unstructured":"Sysmex cooperation. XT-2000i TM and XT1800iTM- Advanced Technology Solutions to Meet your Lab \u2018 s Needs. 2012;L."},{"issue":"8476","key":"ref16","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"JM Bland","year":"1986","journal-title":"Lancet"},{"issue":"5","key":"ref17","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1097\/QAI.0000000000000214","article-title":"WHO multicenter evaluation of FACSCount CD4 and Pima CD4 T-cell count systems: instrument performance and misclassification of HIV-infected patients","volume":"66","author":"D Wade","year":"2014","journal-title":"Journal of acquired immune deficiency syndromes (1999)"},{"issue":"1","key":"ref18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/cyto.b.10016","article-title":"Multiple method comparison: statistical model using percentage similarity","volume":"54","author":"LE Scott","year":"2003","journal-title":"Cytometry Part B, Clinical cytometry"},{"key":"ref19","unstructured":"World Health Organization (WHO). Antiretroviral therapy for HIV infection in adults and adolescents. 2010."},{"key":"ref20","unstructured":"World Health Organization (WHO). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. WHO Guidelines. 2013;(June):272."},{"issue":"12","key":"ref21","doi-asserted-by":"publisher","first-page":"e0145586","DOI":"10.1371\/journal.pone.0145586","article-title":"The BD FACSPresto Point of Care CD4 Test Accurately Enumerates CD4+ T Cell Counts","volume":"10","author":"P Bwana","year":"2015","journal-title":"Plos One"},{"key":"ref22","unstructured":"World Health Organization (WHO). WHO | Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. WHO. World Health Organization; 2016;"},{"issue":"9","key":"ref23","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1056\/NEJMoa1507198","article-title":"A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa","volume":"373","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"ref24","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection","volume":"373","author":"JD Lundgren","year":"2015","journal-title":"The New England journal of medicine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0176323","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T05:48:57Z","timestamp":1569131337000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0176323"}},"subtitle":[],"editor":[{"given":"Lindi-Marie","family":"Coetzee","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,4,27]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,4,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0176323","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,27]]}}}